Skip to main content
SpringerLink
Log in

Estimate of the diabetic retinopathy hazard rates in type 2 diabetic patients with current status data

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Diabetes Retinopathy is an important microvascular complication of diabetes mellitus and estimation of the retinopathy prevalence from cross sectional data is very important. This study is to estimate the hazard rate of diabetic retinopathy when only cross sectional data measuring diabetes prevalence is available. A total of 459 type 2 diabetic patients referred to an Ophthalmology clinic from May to December 2008 were studied. The severity of diabetic retinopathy was graded as per Early Treatment Diabetic Retinopathy Study (ETDRS). Factors associated with occurrence of retinopathy were assessed by the Cox’s proportional hazard model for current status data. Multivariate analysis showed that body mass index, gender, smoking status and family history of diabetes were more independent predictions of diabetic retinopathy, while method of treatment, history of hypertension and duration of diabetes were all significantly associated with the occurrence of diabetic retinopathy. Compared with oral treatment group, those on insulin were more likely to be associated with diabetic retinopathy. From the cross sectional data, it is concluded that diabetic retinopathy hazard rate are less in patients with hypertension and more in patients using insulin and those with long duration of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179–83.

    Article  PubMed  Google Scholar 

  2. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study; Part III: prevalence and risk of diabetic retinopathy when age at diagnosis is thirty or more years. Arch Ophthalmol. 1984;102:527–33.

    Article  PubMed  CAS  Google Scholar 

  3. Fong DS, Aiello L, Gardener TW, King GL, et al. Retinopathy in diabetes. Diabetes Care. 2004;27:84–7.

    Article  Google Scholar 

  4. Semeraro F, Parrinello G, Cancarini A, Pasquini L, Zarra E, Cimino A, et al. Predicting the risk of diabetic retinopathy in type 2 diabetic patients. J Diabet Complicat. 2011;25:292–7.

    Article  Google Scholar 

  5. Henschel V, Heiss C, Mansmann U. Intcox: Iterated Convex Minorant Algorithm for interval censored event data. 2009. http://cran.r-project.org/web/packages/intcox/index.html. Accessed 6 July 2009

  6. Sun J. The statistical analysis of interval-censored failure time data. New York: Springer; 2006.

    Google Scholar 

  7. Wang L, Sun J, Tong X. Efficient estimation for the proportional hazards model with bivariate current status data. Lifetime Data Anal. 2008;14:134–53.

    Article  PubMed  Google Scholar 

  8. Javadi MA, Katibeh M, Dehghan MH, et al. Prevalence of diabetic retinopathy in Tehran province: a population-based study. BMC Ophthalmol. 2009;9:12.

    Article  PubMed  Google Scholar 

  9. Afkhami-Ardekani M, Modrresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18:112–7.

    Article  PubMed  CAS  Google Scholar 

  10. Jamal-u-Din A, Qureshi MB, Khan AJ, Khan MD, Ahmad K. Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan. J Ayub Med Coll. 2006;18:40–3.

    CAS  Google Scholar 

  11. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in southern India: a population based assessment. Br J Ophthalmol. 2002;86:1014–8.

    Article  PubMed  CAS  Google Scholar 

  12. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Mathews DR, et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent sk factors. Arch Ophthalmol. 1998;116:297–303.

    PubMed  CAS  Google Scholar 

  13. Varma R, Torres M, Pena F, Klein R, Azen SP. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1298–306.

    Article  PubMed  Google Scholar 

  14. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XIV (1994) ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217–28.

    Article  PubMed  CAS  Google Scholar 

  15. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol. 1998;42:535–47.

    Article  PubMed  CAS  Google Scholar 

  16. van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol. 2003;121:245–51.

    Article  PubMed  Google Scholar 

  17. Kempen JH, O’Colmain BJ, Lesk MC, Haffner SM, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–63.

    Article  PubMed  Google Scholar 

  18. Dowse GK, Humphrey AR, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147:448–57.

    Article  PubMed  CAS  Google Scholar 

  19. Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol. 2007;52:180–95.

    Article  PubMed  Google Scholar 

  20. Klein R, Klein BE, Moss SE. Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 1997;157:650–6.

    Article  PubMed  CAS  Google Scholar 

  21. West KM, Erdreich LJ, Stober JA. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 1980;29:501–8.

    Article  PubMed  CAS  Google Scholar 

  22. Chaturvedi N, Fuller JH. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care. 1995;18:766–74.

    Article  PubMed  CAS  Google Scholar 

  23. Chen MS, Kao CS, Chang CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114:723–30.

    PubMed  CAS  Google Scholar 

  24. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in southern India. Br J Ophthalmol. 1999;83:937–40.

    Article  PubMed  CAS  Google Scholar 

  25. Looker HC, Krakoff J, Knowler WC, Bennett PH, Klein R, Hanson RL. Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in Pima Indians. Diabetes Care. 2003;26:320–6.

    Article  PubMed  Google Scholar 

  26. Manaviat MR, Rashidi M, Afkhami-Ardekani M. Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. Eur J Ophthalmol. 2008;18:572–7.

    PubMed  CAS  Google Scholar 

  27. Arauz-Pacheco C, Parrott MA, Raskin P. The treatment of hypertension in adult patients with diabetes. Diabetes Care. 2002;25:134–47.

    Article  PubMed  Google Scholar 

  28. Whalent KL, Stewart RD. Pharmacologic management of hypertension in patients with diabetes. Am Fam Physician. 2008;78:1277–82.

    Google Scholar 

  29. Janka HU, Warram JH, Rand LI, Krolewski AS. Risk factors for progression of background retinopathy in long standing IDDM. Diabetes. 1989;38:460–4.

    Article  PubMed  CAS  Google Scholar 

  30. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–13.

    Article  Google Scholar 

  31. Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int. 2002;61:1086–97.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all the patient participants in this study and the staff of Yazd Diabetes Research Center who helped us in collecting data.

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Biostatistics, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran

    Mohsen Askarishahi & Ebrahim Hajizadeh

  2. Diabetes Research Center of Yazd, Shahid Sadoughi University of Medical Science, Yazd, Iran

    Mohammad Afkhami-Ardekani

  3. Department of Ophthalmology, Shahid Sadoughi University of Medical Science, Yazd, Iran

    Masoud Reza Manaviat

Authors
  1. Mohsen Askarishahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ebrahim Hajizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Afkhami-Ardekani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masoud Reza Manaviat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ebrahim Hajizadeh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Askarishahi, M., Hajizadeh, E., Afkhami-Ardekani, M. et al. Estimate of the diabetic retinopathy hazard rates in type 2 diabetic patients with current status data. Int J Diabetes Dev Ctries 32, 203–208 (2012). https://doi.org/10.1007/s13410-012-0092-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-012-0092-0

Keywords

Search

Navigation